Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2
- PMID: 108204
- PMCID: PMC1457553
Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2
Abstract
Staphylococcus aureus opsonization was studied kinetically by: (1) determination of the uptake of [3H]-thymidine labelled bacteria by human PMN's; (2) fluorescent anti-C3 and anti-IgG staining of opsonized bacteria; and (3) measuring bacterial complement consumption. Maximum opsonization in normal serum occurred within 5 min of incubation. About 80% of staphylococci were then taken up by PMN's, and IgG and C3b could be detected on the bacterial surface. In the absence of a functional classical complement pathway, as in sera deficient in C1s and C2 and in MgEGTA chelated serum, maximal opsonization was only achieved after 30--60 min incubation. Opsonization in IgG deficient serum occurred at a rate similar to that found in C2 deficient or MgEGTA chelated serum. Opsonization was greatly enhanced when sera were reconstituted. It was concluded that in IgG deficient serum Staphylococcus aureus opsonization is mediated via the alternative complement pathway. Dilution of normal serum primarily affected the classical complement pathway, resulting in a decreased rate of opsonization. In normal serum IgG did not appear to be a rate-limiting factor. S. Aureus opsonization was best studied by the phagocytosis assay and the fluorescent-antibody technique. Measuring haemolytic complement consumption was found to be an insensitive indicator of bacterial complement activation and opsonization.
Similar articles
-
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.Immunology. 1977 Aug;33(2):191-7. Immunology. 1977. PMID: 415969 Free PMC article.
-
Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.J Immunol. 1982 Oct;129(4):1681-7. J Immunol. 1982. PMID: 7108223
-
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.Immunology. 1979 Jul;37(3):615-21. Immunology. 1979. PMID: 500119 Free PMC article.
-
The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.Immunobiology. 2016 Oct;221(10):1091-101. doi: 10.1016/j.imbio.2016.06.003. Epub 2016 Jun 15. Immunobiology. 2016. PMID: 27424796 Review.
-
Host defence to bacterial infection in the neonate.J Hosp Infect. 1988 Feb;11 Suppl A:320-7. doi: 10.1016/0195-6701(88)90206-x. J Hosp Infect. 1988. PMID: 2896728 Review.
Cited by
-
Phagocytosis and killing of Staphylococcus aureus by human neutrophils.J Innate Immun. 2014;6(5):639-49. doi: 10.1159/000360478. Epub 2014 Apr 5. J Innate Immun. 2014. PMID: 24713863 Free PMC article.
-
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.J Clin Invest. 1982 Feb;69(2):394-404. doi: 10.1172/jci110463. J Clin Invest. 1982. PMID: 7035495 Free PMC article.
-
Decomplementation antigen, a possible determinant of staphylococcal pathogenicity.Infect Immun. 1985 Jan;47(1):41-6. doi: 10.1128/iai.47.1.41-46.1985. Infect Immun. 1985. PMID: 3965409 Free PMC article.
-
Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.Immunology. 1984 Jul;52(3):427-35. Immunology. 1984. PMID: 6086502 Free PMC article.
-
Role of mesothelial cells in peritoneal antibacterial defence.J Clin Pathol. 1991 Jul;44(7):600-4. doi: 10.1136/jcp.44.7.600. J Clin Pathol. 1991. PMID: 1856294 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous